[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100572713":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":41,"collaborators":10,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":47,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":59,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":64,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"First Affiliated Hospital of Zhejiang University","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Radical gastrectomy with membrane dissection",null,[12],"Procedure: distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer",[14],{"type":15,"name":16,"description":16,"armGroupLabels":17,"otherNames":10},"PROCEDURE","distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Tao Wang, Ph.d","CONTACT","+86-197-068-25286","15002740874@163.com",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine","RECRUITING","Hangzhou","Zhejiang","310000","China","CN",{"type":34,"coordinates":35},"Point",[36,37],120.16142,30.29365,{"lat":37,"lon":36},[40],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Jichao Qin","professor","100572713","exploration-of-lymph-node-metastasis-and-tumor-deposit-in-the-posterior-gastric-mesentery-for-distal-gastric-cancer-100572713",false,"NCT06736847","Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery for Distal Gastric Cancer","Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery Following D2 Lymphadenectomy Plus Complete Mesogastric Excision in Patients Who Received Distal Gastrectomy: A Prospective Observational Study","zydgc001","Inclusion Criteria:\n\n1. Aged older than 18 years and younger than 85 years\n2. Primary gastric adenocarcinoma confirmed by preoperative pathology result\n3. cT2-4N0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 7th Edition\n4. Patients who received distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision\n5. American Society of Anesthesiologists (ASA) class I, II, or III\n6. Written informed consent\n\nExclusion Criteria:\n\n1. Negative preoperative biopsy\n2. Too late tumour stage or metastasis (cT4b\u002FM1)\n3. BMI\\>30 kg\u002Fm2\n4. Total gastrectomy or proximal gastrectomy\n5. previous neoadjuvant chemotherapy or radiotherapy\n6. Previous upper abdominal surgery\n7. Combined with other malignant diseases\n8. Reject operation","ALL","18 Years","85 Years",{"count":57,"type":58},200,"ESTIMATED","1 Month","OBSERVATIONAL","This study aims to evaluate lymph node metastasis and tumor deposit in the posterior gastric mesentery following distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer.",[63],"Gastric Carcinoma",[65,66,67,68],"Gastric cancer","Lymph node dissection","Posterior gastric mesentery","Lymph node metastasis","2025-08-25",{"date":71,"type":72},"2025-09-02","ACTUAL",{"date":74,"type":72},"2024-05-01",{"date":76,"type":58},"2027-12-31",{"name":43,"class":6},1]